These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6403175)

  • 1. Effect of 1050 mg fluphenazine decanoate given intramuscularly over six days.
    Cheung HK; Yu EC
    Br Med J (Clin Res Ed); 1983 Mar; 286(6370):1016-7. PubMed ID: 6403175
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs.
    Dreyfuss J; Shaw JM; Ross JJ
    J Pharm Sci; 1976 Sep; 65(9):1310-5. PubMed ID: 966144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant greater loss of medication from the injection site when fluphenazine (Prolixin) decanoate was injected intramuscularly as contrasted with subcutaneously.
    Gelenberg AJ
    J Clin Psychiatry; 1987 Oct; 48(10):425. PubMed ID: 3667545
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma levels of fluphenazine decanoate. Effects of site of injection, massage and muscle activity.
    Soni SD; Wiles D; Schiff AA; Bamrah JS
    Br J Psychiatry; 1988 Sep; 153():382-4. PubMed ID: 3250675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks.
    Carpenter WT; Buchanan RW; Kirkpatrick B; Lann HD; Breier AF; Summerfelt AT
    Am J Psychiatry; 1999 Mar; 156(3):412-8. PubMed ID: 10080557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.
    MacCrimmon DJ; Saxena B; Foley P; Grof P
    Neuropsychobiology; 1978; 4(6):360-5. PubMed ID: 692838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low neuroleptic serum levels in patients receiving fluphenazine decanoate.
    Tune LE; Creese I; Coyle JT; Pearlson G; Snyder SH
    Am J Psychiatry; 1980 Jan; 137(1):80-2. PubMed ID: 6101523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration.
    Simpson GM; Yadalam KG; Levinson DF; Stephanos MJ; Lo ES; Cooper TB
    J Clin Psychopharmacol; 1990 Dec; 10(6):417-21. PubMed ID: 2286711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma fluphenazine levels in patients receiving two doses of fluphenazine decanoate.
    Marder SR; Hubbard JW; Van Putten T; Hawes EM; McKay G; Mintz J; May PR; Midha KK
    Psychopharmacol Bull; 1986; 22(1):264-6. PubMed ID: 3726072
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of extremely low doses of fluphenazine decanoate.
    Geller J
    Am J Psychiatry; 1990 May; 147(5):672. PubMed ID: 2327499
    [No Abstract]   [Full Text] [Related]  

  • 12. Is the treatment of tobacco dependence with fluphenazine decanoate a causal treatment?
    Drtil J; Balasová G; Jandová E; Duchácková K
    Act Nerv Super (Praha); 1990 Dec; 32(4):301-2. PubMed ID: 2082649
    [No Abstract]   [Full Text] [Related]  

  • 13. Late-Onset Rhabdomyolysis Associated With an Intramuscular Injection of Fluphenazine Decanoate.
    Umino M; Kobayashi R; Nisijima K; Suda S
    Prim Care Companion CNS Disord; 2017 Sep; 19(5):. PubMed ID: 28972705
    [No Abstract]   [Full Text] [Related]  

  • 14. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
    Zhang YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the mechanism of absorption of depot neuroleptics: fluphenazine decanoate in sesame oil.
    Luo JP; Hubbard JW; Midha KK
    Pharm Res; 1997 Aug; 14(8):1079-84. PubMed ID: 9279892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fluphenazine enanthate and fluphenazine decanoate on discriminated avoidance response and water drinking behavior in rats.
    Kuribara H; Tadokoro S
    Psychopharmacology (Berl); 1979 Sep; 65(1):1-6. PubMed ID: 116283
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical pharmacokinetics of the depot antipsychotics.
    Jann MW; Ereshefsky L; Saklad SR
    Clin Pharmacokinet; 1985; 10(4):315-33. PubMed ID: 2864156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidly progressive tardive dyskinesia in AIDS.
    Shedlack KJ; Soldato-Couture C; Swanson CL
    Biol Psychiatry; 1994 Jan; 35(2):147-8. PubMed ID: 8167213
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
    Wistedt B
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.